<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Kissei Pharmaceutical Co.%2C Ltd from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Kissei Pharmaceutical Co.%2C Ltd news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 23:19:03 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Kissei+Pharmaceutical+Co.%2C+Ltd" rel="self" type="application/rss+xml" />

	
<item><title>Kissei Pharmaceutical Co., Ltd.-Company Report - new market report released</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028300&amp;HITNO=0&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028300&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532669618%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4028300&amp;HITNO=0&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4028300&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2532669618%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Silodosin, Indicated for Benign Prostatic Hyperplasia (BPH), Has Been Approved By the European Commission</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029917&amp;HITNO=1&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029917&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533334208%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4029917&amp;HITNO=1&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4029917&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2533334208%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Ipsen debuts Decapeptyl in France, Recordati gains EU clearance for silodosin</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018187&amp;HITNO=2&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018187&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525515933%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4018187&amp;HITNO=2&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4018187&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2525515933%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Letter:</description></item>
<item><title>Recordati : Silodosin Approved By The European Commission For The Treatment Of The Signs And Symptoms Of Benig</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4011541&amp;HITNO=3&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4011541&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522987237%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4011541&amp;HITNO=3&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4011541&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2522987237%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical News Today:</description></item>
<item><title>Recordati : Silodosin (urorec(r)/silodyx) Approved By The European Commission For The Treatment Of The Signs A</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4004337&amp;HITNO=4&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4004337&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519907236%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4004337&amp;HITNO=4&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4004337&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2519907236%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Kissei Pharmaceutical Co., Ltd. - Financial And Strategic Analysis Review - New Report Published</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3762594&amp;HITNO=5&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3762594&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2391981954%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3762594&amp;HITNO=5&amp;MSIZE=6&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Kissei%20Pharmaceutical%20Co.,%20Ltd&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3762594&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2391981954%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>OfficialSpin:</description></item>
</channel></rss>